Coston McIsaac & Partners’s iShares Biotechnology ETF IBB Stock Holding History

Coston McIsaac & Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14K	Hold	74	–	–	﹤0.01%	539
2026 Q1	$12K	Hold	74	–	–	﹤0.01%	547
2025 Q4	$12K	Hold	74	–	–	﹤0.01%	545
2025 Q3	$10K	Hold	74	–	–	﹤0.01%	544
2025 Q2	$9K	Hold	74	–	–	﹤0.01%	539
2025 Q1	$9K	Hold	74	–	–	﹤0.01%	513
2024 Q4	$9K	Hold	74	–	–	﹤0.01%	495
2024 Q3	$10	Hold	74	–	–	﹤0.01%	492
2024 Q2	$10K	Sell	74 -40	-35%	-$5.34K	﹤0.01%	468
2024 Q1	$15K	Hold	114	–	–	﹤0.01%	423
2023 Q4	$15K	Hold	114	–	–	0.01%	427
2023 Q3	$13K	Hold	114	–	–	﹤0.01%	441
2023 Q2	$14K	Hold	114	–	–	﹤0.01%	457
2023 Q1	$14K	Sell	114 -151	-57%	-$19.8K	0.01%	457
2022 Q4	$34	Buy	265 +151	+132%	+$19.5K	0.01%	336
2022 Q3	$13K	Hold	114	–	–	0.01%	395
2022 Q2	$13K	Buy	+114	New	+$13.5K	0.01%	251

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Coston McIsaac & Partners's IBB Position: Q2 2026 in Review

Coston McIsaac & Partners held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 74 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Coston McIsaac & Partners first reported a position in IBB in Q2 2022 and has held it in 17 quarters since. The position peaked at $15K in Q1 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Coston McIsaac & Partners held 74 shares of iShares Biotechnology ETF worth $14K as of Q2 2026.
Coston McIsaac & Partners left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Coston McIsaac & Partners's portfolio in Q2 2026, its #539 holding.
Coston McIsaac & Partners first reported a position in iShares Biotechnology ETF in Q2 2022 and has held it in 17 quarters since.
Coston McIsaac & Partners's iShares Biotechnology ETF position peaked at $15K in Q1 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Coston McIsaac & Partners's 13F filing for Q2 2026, filed 12 Aug 2026.